Immunosuppressive regimen for renal transplantatio

Immunosuppressive regimen for renal transplantation

Immunosuppression for renal transplantation generally comprises induction therapy with the anti-CD25 monoclonal - antibody basiliximab followed by a maintenance regimen of a calcineurin inhibitor (most usually tacrolimus), an antipro - liferative agent (usually mycophenolic acid) and corticosteroid (prednisolone). The anti-CD52 monoclonal antibody alemtu - zumab can be used for induction instead of basiliximab for -

Figure 88.15 Completed laparoscopic dissection of the left kidney, which is ready for stapling of the vessels and removal in an Endocatch bag.

avoidance strategy in patients at high risk of developing diabe tes post transplantation.